Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics
| Autor: | Underberg, James A., Blaha, Michael J., Jackson, Elizabeth J., Jones, Peter H. |
|---|---|
| Zdroj: | In The American Journal of Medicine October 2017 130(10):1233-1233 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|